Padippurayil Faizal¹, Balasubramanian Satheesan², Bhavya Vinod³, Kunnethedam Thomas Augusti^1*

Show more
¹ Department of Medical Biochemistry, School of Health Sciences, Kannur University Thalassery Campus, Thalassery, India.
² Department of Surgical Oncology, Malabar Cancer Centre, Thalassery, India.
³ Department of Medical Microbiology, School of Health Sciences, Kannur University Thalassery Campus, Thalassery, India.
Show less

Abstract: Studies have extensively demonstrated the activation of enzymic and nonenzymic antioxidants as well as decrease of lipid peroxidation status after pomegranate intake without any observable toxicity in animal models. Comparing to animal model studies, human trials are less done on these aspects. Cellular damage caused by reactive oxygen species appears to be a major contributor in ageing and other degenerative diseases such as cancer, cardiovascular diseases, cataracts, compromised immune system, rheumatoid arthritis and brain dysfunction. Several literatures show that pomegranate has been used as a folk medicine from ancient times itself. As per the reviews, pomegranate fruit possesses antioxidant, anti-inflammatory, antiatherogenic and antitoxic effects. The primary objective of this study was to evaluate the circulatory levels of selected antioxidant and lipid peroxidation marker in healthy human volunteers before and after pomegranate intake for a period of 0 - 90 days. As the secondary objective of the study, we also assessed the toxic effects of pomegranate supplementation by determining Hepatobiliary and Renal function tests. The final result showed that majority of the study population showed a significant increase in enzymic and non-enzymic antioxidants and a decrease in oxidative stress after pomegranate intake without any observable toxicity in liver function and renal function. The significant healthy variations were more after the intake of pomegranate for a period of 90 days than that of 45 days.

Keywords: Oxidative stress, Reactive Oxygen Species, Phytochemicals, Pomegranate

Cite this paper: Faizal, P. , Satheesan, B. , Vinod, B. and Thomas Augusti, K. (2017) Evaluation of Antioxidant, Lipid Peroxidation and Toxic Effects after Pomegranate Intake in Healthy Human Volunteers. International Journal of Clinical Medicine, 8, 12-20. doi: 10.4236/ijcm.2017.81002.

References

[1]   Temple, N.J. (2000) Antioxidants and Disease: More Questions Than Answers. Nutrition Research, 20, 449-459.
https://doi.org/10.1016/s0271-5317(00)00138-x

[2]   Halliwell, B., Gutteridge, J. and Cross, C.E. (1992) Free Radicals, Antioxidants, and Human Disease: Where Are We Now? The Journal of Laboratory and Clinical Medicine, 119, 598-620.

[3]   McCall, M.R. and Frei, B. (1999) Can Antioxidant Vitamins Materially Reduce Oxidative Damage in Humans? Free Radical Biology and Medicine, 26, 1034-1053.
https://doi.org/10.1016/S0891-5849(98)00302-5

[4]   Langlery, P. (2000) Why a Pomegranate? BJ, 321, 1153.

[5]   Gil, M.I., Tomás-Barberán, F.A., Hess-Pierce, B., Holcroft, D.M. and Kader, A.A. (2000) Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and Processing. Journal of Agricultural and Food Chemistry, 48, 4581-4589.
https://doi.org/10.1021/jf000404a

[6]   Nasr, C.B., Ayed, N. and Metche, M. (1996) Quantitative Determination of the Polyphenolic Content of Pomegranate Peel. Zeitschrift für Lebensmittel-Untersuchung und Forschung, 203, 374-378.
https://doi.org/10.1007/BF01231077

[7]   Tzulker, R., Glazer, I., Bar-Ilan, I., Holland, D., Aviram, M. and Amir, R. (2007) Antioxidant Activity, Polyphenol Content, and Related Compounds in Different Fruit Juices and Homogenates Prepared from 29 Different Pomegranate Accessions. Journal of Agricultural and Food Chemistry, 55, 9559-9570.
https://doi.org/10.1021/jf071413n

[8]   Rosenblat, M. and Aviram, M. (2006) Antioxidative Properties of Pomegranate: In Vitro Studies. Pomegranates: Ancient Roots to Modern Medicine, 43, 31-43.

[9]   Seeram, N.P., Lee, R. and Heber, D. (2004) Bioavailability of Ellagic Acid in Human Plasma after Consumption of Ellagitannins from Pomegranate (Punica granatum L.) Juice. Clinica Chimica Acta, 348, 63-68.
https://doi.org/10.1016/j.cccn.2004.04.029

[10]   Azadzoi, K.M., Schulman, R.N., Aviram, M. and Siroky, M.B. (2005) Oxidative Stress in Arteriogenic Erectile Dysfunction: Prophylactic Role of Antioxidants. The Journal of Urology, 174, 386-393.
https://doi.org/10.1097/01.ju.0000161209.39959.67

[11]   Chance, B.A. and Maehlly, C. (1995) Assay of Catalase and Peroxidase. Methods in Enzymology, 2, 764-765.
https://doi.org/10.1016/S0076-6879(55)02300-8

[12]   Marklund, S. and Marklund, G. (1974) Involvement of the Superoxide Anion Radical in the Autoxidation of Pyrogallol and a Convenient Assay for Superoxide Dismutase. European Journal of Biochemistry, 47, 469-474.
https://doi.org/10.1111/j.1432-1033.1974.tb03714.x

[13]   Paglia, D.E. and Valentine, W.N. (1967) Studies on the Quantitative and Qualitative Characterization of Erythrocytes Glutathione Peroxidase. Journal of Laboratory and Clinical Medicine, 70, 158-169.

[14]   Goldberg, D.M. and Spooner, R.J. (1983) Assay of Glutathione Reductase. In: Bergmeyen, H.V., Ed., Methods of Enzymatic Analysis, 3rd Edition, Vol. 3, Verlog Chemie, Deerfiled Beach, 258-265.

[15]   Harvey, J.W. and Beutler, E. (1982) Binding of Heme by Glutathiones-S Transferases—A Possible Role of Erythrocyte Enzyme. Blood, 60, 1227-1230.

[16]   Beutler, E. (1975) Reduced Glutathione (GSH). In: Bergmeyen, H.V., Ed., Red Blood Cell Metabolism: A Manual of Biochemical Methods, 2nd Edition, Grune and Stratton, New York, 112-114.

[17]   Roe, J.H. (1961) Ascorbic Acid in Blood and Urine. In: Seligson, D., Ed., Standard Methods in Clinical Chemistry, Vol. 3, Academic Press, New York, 35-45.

[18]   Beuge, J.A. and Aust, S.D. (1978) Microsomal Lipid Peroxidation. Methods in Enzymology, 105, 302-310.
https://doi.org/10.1016/S0076-6879(78)52032-6

[19]   Pearlman, F.C. and Lee, R.T. (1974) Detection and Measurement of Total Bilirubin in Serum, with Use of Surfactants as Solubilizing Agents. Clinical Chemistry, 20, 447-453.

[20]   Koller, A. (1984) Proteins. In: Kaplan, L.A. and Pesce, A.J., Eds., Clinical Chemistry: Theory, Analysis and Correlation, Mosby, Toronto, 1268-1327.

[21]   Moss, D.W. and Henderson, A.K. (1994) Clinical Enzymology. In: Burtis, C.A and Ashwood, E.R., Eds., Tietz Textbook of Clinical Chemistry, 3rd Edition, WB Saunders, Philadelphia, 617-621.

[22]   Murray, R.L. (1984) Non Protein Nitrogen Compounds. In: Kaplan, L.A. and Pesce, A.J., Eds., Clinical Chemistry: Theory, Analysis and Correlation, Mosby, Toronto, 1230-1268.